Greater Cincinnati pharmaceutical firm raises $40M

Story excerpt provided by Cincinnati Business Courier.

Written by Barrett J. Brunsman.

Aerpio Pharmaceuticals Inc. revealed today it raised $40 million by issuing 8 million shares of common stock, which will be used to develop clinical programs such as a treatment for eye disease related to diabetes.

The stock, priced at $5 a share, was sold to “accredited investors.” The offering was exempt from registration under the Securities Act.

Click here to read the complete article.

Originally published March 16, 2017.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: